VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Diabetes is a leading global health and economic challenge, affecting over 800 million people worldwide, with over 80% ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

It also aligns with Canada’s Indo-Pacific Strategy and our mutual interests. Through this Strategic Partnership, Canada is working to further grow ASEAN-Canada cooperation under three pillars: ...